Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
BIOCRYST PHARMACEUTICALS INC has filed 1,964 SEC EDGAR filings since 14 Feb 1995

SEC filing history

Showing 626-650 of 1,000 matching filings.

Per page
25
Current page
26
8-K File 000-23186

FORM 8-K

Filing date
06 Nov 2019
Reporting date
06 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
05 Nov 2019
Reporting date
05 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
01 Nov 2019
Reporting date
01 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
28 Oct 2019
Reporting date
28 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
26 Sep 2019
Reporting date
23 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Sep 2019
Reporting date
20 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
24 Sep 2019
Reporting date
20 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
23 Sep 2019
Reporting date
17 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
16 Sep 2019
Reporting date
10 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Sep 2019
Reporting date
01 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Sep 2019
Reporting date
01 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Sep 2019
Reporting date
01 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Sep 2019
Reporting date
01 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
06 Aug 2019
Reporting date
06 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jul 2019
Reporting date
01 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
03 Jul 2019
Reporting date
01 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
01 Jul 2019
Reporting date
25 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
01 Jul 2019
Reporting date
01 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
27 Jun 2019
Reporting date
27 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-231942

FORM S-8

Filing date
04 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-23186

FORM 8-K

Filing date
04 Jun 2019
Reporting date
29 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 May 2019
Reporting date
29 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 May 2019
Reporting date
29 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 May 2019
Reporting date
29 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .